ARKG vs INDA
ARK Genomic Revolution ETF vs iShares MSCI India ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
INDA—
iShares MSCI India ETF
Indian large- and mid-cap equities.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | INDA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
INDA top holdings
Holdings data unavailable for INDA.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About INDA
INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities.